Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Consumption of sweetened, dried cranberries may reduce urinary tract infection incidence in susceptible women--a modified observational study.

Burleigh AE, Benck SM, McAchran SE, Reed JD, Krueger CG, Hopkins WJ.

Nutr J. 2013 Oct 18;12(1):139. doi: 10.1186/1475-2891-12-139.

2.

Lack of association between the Tlr4 (Lpsd/Lpsd) genotype and increased susceptibility to Escherichia coli bladder infections in female C3H/HeJ mice.

Suhs KA, Marthaler BR, Welch RA, Hopkins WJ.

MBio. 2011 May 31;2(3):e00094-11. doi: 10.1128/mBio.00094-11. Print 2011.

3.

Quantitative trait loci associated with susceptibility to bladder and kidney infections induced by Escherichia coli in female C3H/HeJ mice.

Hopkins WJ, Elkahwaji J, Kendziorski C, Moser AR, Briggs PM, Suhs KA.

J Infect Dis. 2009 Feb 1;199(3):355-61. doi: 10.1086/595987.

4.

Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial.

Hopkins WJ, Elkahwaji J, Beierle LM, Leverson GE, Uehling DT.

J Urol. 2007 Apr;177(4):1349-53; quiz 1591.

PMID:
17382730
5.

Acute acrolein-induced cystitis in mice.

Bjorling DE, Elkahwaji JE, Bushman W, Janda LM, Boldon K, Hopkins WJ, Wang ZY.

BJU Int. 2007 Jun;99(6):1523-9. Epub 2007 Mar 6.

6.

Chronic bacterial infection and inflammation incite reactive hyperplasia in a mouse model of chronic prostatitis.

Elkahwaji JE, Zhong W, Hopkins WJ, Bushman W.

Prostate. 2007 Jan 1;67(1):14-21.

PMID:
17075821
7.

Mouse model for acute bacterial prostatitis in genetically distinct inbred strains.

Elkahwaji JE, Ott CJ, Janda LM, Hopkins WJ.

Urology. 2005 Oct;66(4):883-7.

PMID:
16230175
8.

Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections.

Uehling DT, Hopkins WJ, Elkahwaji JE, Schmidt DM, Leverson GE.

J Urol. 2003 Sep;170(3):867-9.

PMID:
12913718
9.

Inheritance of susceptibility to induced Escherichia coli bladder and kidney infections in female C3H/HeJ mice.

Hopkins WJ, Elkahwaji JE, Heisey DM, Ott CJ.

J Infect Dis. 2003 Feb 1;187(3):418-23. Epub 2003 Jan 24.

PMID:
12552425
10.

Vaccine Development for the Prevention of Urinary Tract Infections.

Hopkins WJ, Uehling DT.

Curr Infect Dis Rep. 2002 Dec;4(6):509-513.

PMID:
12433326
12.

Vaginal mucosal immunization for recurrent urinary tract infection: extended phase II clinical trial.

Uehling DT, Hopkins WJ, Beierle LM, Kryger JV, Heisey DM.

J Infect Dis. 2001 Mar 1;183 Suppl 1:S81-3. No abstract available.

PMID:
11171022
13.

The urinary tract response to entry of pathogens.

Uehling DT, Johnson DB, Hopkins WJ.

World J Urol. 1999 Dec;17(6):351-8. Review.

PMID:
10654365
14.

Evaluation of a familial predisposition to recurrent urinary tract infections in women.

Hopkins WJ, Uehling DT, Wargowski DS.

Am J Med Genet. 1999 Apr 23;83(5):422-4. No abstract available.

PMID:
10232756
16.

Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains.

Hopkins WJ, Gendron-Fitzpatrick A, Balish E, Uehling DT.

Infect Immun. 1998 Jun;66(6):2798-802.

18.
19.

Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial.

Uehling DT, Hopkins WJ, Balish E, Xing Y, Heisey DM.

J Urol. 1997 Jun;157(6):2049-52.

PMID:
9146577
20.
21.

Western blot analysis of anti-Escherichia coli serum immunoglobulins in women susceptible to recurrent urinary tract infections.

Hopkins WJ, Xing Y, Dahmer LA, Balish E, Uehling DT.

J Infect Dis. 1995 Dec;172(6):1612-6.

PMID:
7594729
22.

Induction of urinary tract infection by intraurethral inoculation with Escherichia coli: refining the murine model.

Hopkins WJ, Hall JA, Conway BP, Uehling DT.

J Infect Dis. 1995 Feb;171(2):462-5.

PMID:
7844391
24.

Phase I clinical trial of vaginal mucosal immunization for recurrent urinary tract infection.

Uehling DT, Hopkins WJ, Dahmer LA, Balish E.

J Urol. 1994 Dec;152(6 Pt 2):2308-11.

PMID:
7966729
25.

Reduction of bacteriuria and pyuria using cranberry juice.

Hopkins WJ, Heisey DM, Jonler M, Uehling DT.

JAMA. 1994 Aug 24-31;272(8):588-9; author reply 589-90. No abstract available.

PMID:
8057504
26.

Vaginal immunization of monkeys against urinary tract infection with a multi-strain vaccine.

Uehling DT, Hopkins WJ, James LJ, Balish E.

J Urol. 1994 Jan;151(1):214-6.

PMID:
8254817
27.

Congenital immunodeficiencies in mice increase susceptibility to urinary tract infection.

Hopkins WJ, James LJ, Balish E, Uehling DT.

J Urol. 1993 Apr;149(4):922-5.

PMID:
8455276
28.

Immunization against urinary tract infection with a multi-valent vaginal vaccine.

Uehling DT, James LJ, Hopkins WJ, Balish E.

J Urol. 1991 Jul;146(1):223-6.

PMID:
2056594
29.
30.

Adherence of uropathogenic E. coli to differentiated human uroepithelial cells grown in vitro.

Hopkins WJ, Reznikoff CA, Oberley TD, Uehling DT.

J Urol. 1990 Jan;143(1):146-9.

PMID:
2104636
31.

Urinary glycosaminoglycan levels following induced cystitis in monkeys.

Uehling DT, Kelley E, Hopkins WJ, Balish E.

J Urol. 1988 May;139(5):1103-5.

PMID:
3283382
32.
33.

Vaginal immunization against induced cystitis in monkeys.

Uehling DT, Hopkins WJ, Jensen J, Balish E.

J Urol. 1987 Feb;137(2):327-9.

PMID:
3543412
34.

In vitro and in vivo adherence of uropathogenic Escherichia coli strains.

Hopkins WJ, Jensen JL, Uehling DT, Balish E.

J Urol. 1986 Jun;135(6):1319-21.

PMID:
2872339
35.

Tolerance rendered by neonatal treatment with anti-idiotypic antibodies: induction and maintenance in athymic mice.

Kim BS, Hopkins WJ.

Cell Immunol. 1978 Feb;35(2):460-5. No abstract available.

PMID:
620437
36.

Restoration of suppressor function in athymic mice.

Hopkins WJ.

Immunology. 1978 Feb;34(2):309-13.

38.

Dissimilation of C14-labeled glucose by Serratia marcescens.

WASSERMAN AE, HOPKINS WJ.

J Bacteriol. 1958 Apr;75(4):492-3. No abstract available.

39.

Effect of freeze-drying on some enzyme systems of Serratia marcescens.

WASSERMAN AE, HOPKINS WJ.

Appl Microbiol. 1958 Jan;6(1):49-52. No abstract available.

40.

Studies in the recovery of viable cells of freeze-dried Serratia marcescens.

WASSERMAN AE, HOPKINS WJ.

Appl Microbiol. 1957 Sep;5(5):295-300. No abstract available.

41.

Endogenous respiration of Serratia marcescens and oxidation of added carbohydrates.

WASSERMAN AE, HOPKINS WJ.

Proc Soc Exp Biol Med. 1957 Aug-Sep;95(4):708-10. No abstract available.

PMID:
13465779
42.

A research for inhibitors of prostate growth stimulators.

SCOTT WW, HOPKINS WJ, LUCAS WM, TESAR C.

J Urol. 1957 Apr;77(4):652-9. No abstract available.

PMID:
13417307
43.

Lack of conversion in vivo of delta 4 androstenedione-3, 17 to a more active androgen by passage through the liver.

MARDEN HE Jr, HOPKINS WJ, SCOTT WW.

J Urol. 1957 Feb;77(2):315-7. No abstract available.

PMID:
13406885

Supplemental Content

Loading ...
Support Center